Home / Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial unknow ★ 5.0 · 28 reads Sign in to save this Request CodeZLIB.IO18490970 Published2022 Pages1 LanguageUnknown